UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 2, 2014
OphthaliX Inc.
(Exact Name of Registrant as Specified in its Charter)
| | |
Delaware | 000-52545 | 88-0445167 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
|
10 Bareket Street, Petach Tikva, Israel 4951778 |
(Address of Principal Executive Offices) (Zip Code) |
Registrant’s telephone number, including area code: +(972) 3-9241114
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
.Written communications pursuant to Rule 425 under the Securities Act
.Soliciting material pursuant to Rule 14a-12 under the Exchange Act
.Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
.Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 2, 2014, Barak Singer ceased serving as Chief Executive Officer of OphthaliX, Inc. (the “Company”) by mutual agreement with the Company. There were no disagreements between Mr. Singer and the Company or any officer or director of the Company in connection with Mr. Singer’s cessation as Chief Executive Officer of the Company. Mr. Singer will remain as an employee of the Company (but not Chief Executive Officer) through July 28, 2014. On the same day, Dr. Pnina Fishman, the Company’s current Chairman, was appointed to serve as the interim Chief Executive Officer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OphthaliX Inc.
Date: June 3, 2014
By:
/s/ Pnina Fishman
Pnina Fishman, Interim CEO
2
